<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3C83A8CE-8C98-462F-BD2D-7E8E5B913716"><gtr:id>3C83A8CE-8C98-462F-BD2D-7E8E5B913716</gtr:id><gtr:name>Chirotech Technology</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/23494327-58ED-4BFE-B42D-0FF928E0D06F"><gtr:id>23494327-58ED-4BFE-B42D-0FF928E0D06F</gtr:id><gtr:name>Isogenica</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Life Sciences</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/536116AC-C155-4A24-A743-309BD68E50CE"><gtr:id>536116AC-C155-4A24-A743-309BD68E50CE</gtr:id><gtr:name>Defence Science &amp; Tech Lab DSTL</gtr:name><gtr:address><gtr:line1>Defence Science &amp; Tech Lab - MOD</gtr:line1><gtr:line2>Porton Down</gtr:line2><gtr:line4>Salisbury</gtr:line4><gtr:postCode>SP4 0JQ</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>CO_FUNDER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:line4>Swindon</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SN2 1ET</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>CO_FUNDER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3C83A8CE-8C98-462F-BD2D-7E8E5B913716"><gtr:id>3C83A8CE-8C98-462F-BD2D-7E8E5B913716</gtr:id><gtr:name>Chirotech Technology</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/23494327-58ED-4BFE-B42D-0FF928E0D06F"><gtr:id>23494327-58ED-4BFE-B42D-0FF928E0D06F</gtr:id><gtr:name>Isogenica</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F89ADA6C-35D9-413C-B7E2-FB467F123B08"><gtr:id>F89ADA6C-35D9-413C-B7E2-FB467F123B08</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Kitney</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E7C86917-1709-410C-B3A6-4A3C56F9B32D"><gtr:id>E7C86917-1709-410C-B3A6-4A3C56F9B32D</gtr:id><gtr:firstName>Geoffrey</gtr:firstName><gtr:surname>Baldwin</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FJ020036%2F1"><gtr:id>BFC8C3D1-C21F-45EF-B173-4B6E2AD6F3C5</gtr:id><gtr:title>Logic-directed evolution of new biosensor molecules in vivo</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/J020036/1</gtr:grantReference><gtr:abstractText>The ability to rapidly and accurately detect small molecules has widespread use within security and defence contexts such as detection of explosives, biological agents or pathogens. This project will develop a new platform for the development of novel sensors. Sensors require highly specific detection of molecules in very low concentrations. The use of biological approaches for this purpose is attractive since many biological systems have evolved for precisely this purpose. While biological diversity offers a rich source of variety, it is ultimately limited to what can be isolated and characterised. In vitro methods for evolving new biological functionality and diversity have proven useful but are ultimately limited in the range of biological diversity that can be sampled. This project will develop a prototype for the evolution of new biological specificity in vivo, with feedback bio-'logic' circuitry that will enable end-point evolution of biological systems to new specificities. The isolation of new proteins with altered specificity will be essential for the creation of a new generation of biosensors.</gtr:abstractText><gtr:technicalSummary>This proposal seeks to develop a new platform for the development of new-to-nature protein specificities suitable for use in biosensor devices. We will develop a novel method for the directed evolution of new specificities in signal transduction systems. We have developed an in vivo system in bacteria that is able to direct mutation to specific target genes, thus providing the basis for a mechanism of targeted directed evolution in vivo. This project will create a biological logic circuit that will self-limit the evolution to the point when a new specificity has been created, at this point the evolution will stop and a selectable output will be switched on. We have termed this end-point evolution.

The key problem in creating new biological specificity is identifying it. The sequence space in biological diversity is so vast, that identifying the one mutant that has the desired specificity is difficult. This project aims to tackle this directly by the design, modelling and implementation of genetic control circuits: 'Bio-Logic'. This will be programmed for end-point evolution so that the desired phenotype will switch off further mutation and switch on an output and selectable marker. The ability to threshold the response and increase stringency of selection is important and will come from lowering the concentration of the response molecule for which specificity is being engineered, and/or increasing the stringency of selection.</gtr:technicalSummary><gtr:potentialImpactText>The heightened terrorist threat has lead to the requirement for rapid and accurate detection of chemical and biological agents, as well as explosives. It must be considered that although the perceived threat from biological agents is low, recent enhancements in technologies such as gene synthesis, means that threat levels should not be treated as non-existent, nor indeed unchanging. The ability to detect biologically infectious agents is a strategic security requirement as well as a medical challenge. The development of cheap and easy to deploy explosives sensors in the environment could have a great impact on reducing the combat threat of expolsive devices, such as landmines and improvised explosive devices, as well as reducing the civilian impact from the millions of landmines that have been left in the ground. We therefore consider that the development of sensors for infectious agents and/or explosives may have the greatest potential for a step-change in technological driven approaches to these key problems.

Imagine a real-time explosives detector that can 'smell' the presence of an IED before it is reached, or identify airline passengers who have been in contact with restricted chemicals. Imagine a pathogen detection system that can easily detect water borne pathogens in remote and inaccessible locations, or identify an infection before it poses a clinical threat.

There is an increasing demand for new fast and accurate sensor technology and these futuristic scenarios are not necessarily far off. Both of the targets identified above require the detection of small molecules at very low concentrations. The exquisite molecular recognition that proteins are capable of provides an ideal platform for the basis of recognition. However, its key limitation is the ability to develop new specificities for molecular recognition. This proposal seeks to tackle this issue directly in a format that is readily adaptable for new molecular targets. This can therefore provide a technological platform that can be applied to the rapid development of new sensors. This has the potential to transform the pathway to the development of new biosensors.</gtr:potentialImpactText><gtr:fund><gtr:end>2014-01-11</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2012-11-12</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>127392</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Chirotech Technology</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Dr. Reddys</gtr:description><gtr:id>5DE9BEB3-BF1C-4F0C-AB05-9B658CE70E6A</gtr:id><gtr:impact>BBSRC Biocatnet proof of concept fund</gtr:impact><gtr:outcomeId>56d97f6ae8f0c0.75392923-1</gtr:outcomeId><gtr:partnerContribution>Chirotech have provided industrial relevance and access to their enzymes.</gtr:partnerContribution><gtr:piContribution>We have translated our DNA assembly technology into Chirotech and they are now implementing this throughout their operation and Dr. Reddys. This has led to a BBSRC Biocatnet proof of concept funding to further develop this pipeline for developing optimised workflows and enhanced biological systems.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Isogenica</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Isogenica collaboration</gtr:description><gtr:id>65B20E3B-B694-480E-BEBC-85254D2E1B2F</gtr:id><gtr:impact>Innovate UK grant</gtr:impact><gtr:outcomeId>56d97fd476fd20.51252011-1</gtr:outcomeId><gtr:partnerContribution>They have provided experience, context and advice.</gtr:partnerContribution><gtr:piContribution>We have brought our DNA assembly technology to Isogenica</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Invited seminar at LMU Munich</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C91E8756-77E1-468C-8A9F-708DF03BDE52</gtr:id><gtr:impact>I was invited to give a plenary talk at the Institute retreat.</gtr:impact><gtr:outcomeId>56d989ae3c8527.93547326</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BioSynSys 2015 Biologie de synthese et des systemes</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4A395890-03C1-4A24-B332-323A9D6EFD04</gtr:id><gtr:impact>The establishment of a French GDR for systems and synthetic biology is intended to bring together the collective efforts of the French nation in this area of research as well as providing a method for further international interaction. I was invited as a plenary speaker to their inaugural conference.</gtr:impact><gtr:outcomeId>56d9866828a2b0.81999907</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://biosynsys2015.sciencesconf.org/?lang=en</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar at University of Stuttgart</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>52C75B84-2182-4B04-9871-0D79AE4FF36D</gtr:id><gtr:impact>I was invited to give a seminar to the Institut f&amp;uuml;r Bioverfahrenstechnik</gtr:impact><gtr:outcomeId>56d98960a2c461.31803100</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Workshop: Worldviews and values in Synthetic Biology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8E073C96-A136-4F68-AC95-004D5F865C4B</gtr:id><gtr:impact>The presentation was integrated into two days of discussion amongst workshop participants. The outcome of the workshop was a public document that has been widely disseminated.
http://synenergene.eu/resource/summary-report-paris-workshop-worldviews-and-values-synthetic-biology


The outcome of the workshop was a public document that has been widely disseminated.
http://synenergene.eu/resource/summary-report-paris-workshop-worldviews-and-values-synthetic-biology</gtr:impact><gtr:outcomeId>5460aad3dffe17.70504774</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://synenergene.eu/resource/summary-report-paris-workshop-worldviews-and-values-synthetic-biology</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit to WITS University, South Africa</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AEC19EFE-A8F4-44F8-B225-2015389FEF41</gtr:id><gtr:impact>The talk generated a lot of interest and increased peoples awareness of synthetic biology.

Created a new collaboration that will facilitate sharing of tools, resources and ideas with a developing nation.</gtr:impact><gtr:outcomeId>5460ad6b8fd605.28665940</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Workshop: Synthetic biology: containment and release of engineered micro-organisms, Kings College 2013</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C144E537-96BD-4D6E-AAF0-43945D13061B</gtr:id><gtr:impact>I was extensively involved in the discussions during the workshop

The workshop produced a Scoping Report, which was used as evidence by the Secretariat of the Subsidiary Body on Scientific, Technical and Technological Advice (SBSTTA) of the Convention on Biological Diversity, for its preparatory work to determine whether synthetic biology should be identified as a 'New &amp;amp; Emerging Issue relating to the conservation and sustainable use of biodiversity&amp;quot; under the Convention.</gtr:impact><gtr:outcomeId>5460b1dd4a5a67.38308889</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:url>http://www.kcl.ac.uk/sspp/departments/sshm/research/csynbi-PDFs/Scoping-Report.pdf</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Research conference - Industrial Biotechnology Dalian, China 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E16AE79A-94AE-4D99-AD97-BD4E5248BE61</gtr:id><gtr:impact>Stimulated discussions and I made a contact with industry who is interested in using our technology

I made a contact with industry who is interested in using our technology</gtr:impact><gtr:outcomeId>5460ab7b802864.00967980</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit to CSIC Madrid</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>03A52CC5-5E49-496B-8AEC-95BCFD8B4019</gtr:id><gtr:impact>This was a 3 day visit to the laboratory of Victor de Lorenzo, to share our ideas and practices and to develop new ideas and projects.

There were many discussions during the 3 days that cross-fertilised a lot of ideas.</gtr:impact><gtr:outcomeId>5460ae67b4ef06.35218658</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>347000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Innovate UK</gtr:description><gtr:end>2015-07-02</gtr:end><gtr:fundingOrg>Innovate UK</gtr:fundingOrg><gtr:fundingRef>101847</gtr:fundingRef><gtr:id>3C66D8DF-D421-4AE0-8032-E99F24FC7153</gtr:id><gtr:outcomeId>56d980c1448287.81332324</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>221606</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>EU Marie Curie IEF Fellowship</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>628019</gtr:fundingRef><gtr:id>5808958D-4776-416A-8DB1-1CB61375FA3D</gtr:id><gtr:outcomeId>5460b3148150b9.71235488</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>99000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Network in Biotechnology</gtr:description><gtr:end>2016-05-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>Sub project from University of Manchester who hold the main Network award</gtr:fundingRef><gtr:id>401F240A-88D0-4B8B-A4ED-C3A41E6BB743</gtr:id><gtr:outcomeId>56d980650b4054.29124713</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5074187</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SynbiCITE - an Imperial College led Innovation and Knowledge Centre (IKC) in Synthetic BiologY</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/L011573/1</gtr:fundingRef><gtr:id>C04A4CC1-1BF1-4908-B79F-63C098D99DDC</gtr:id><gtr:outcomeId>56d984af0898a2.51966937</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2010000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC Innovation and Knowledge Centre in Synthetic Biology - 24 month review</gtr:description><gtr:end>2018-11-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>(EP/N023854/1</gtr:fundingRef><gtr:id>B412061F-286D-4220-9921-B63C7352FB88</gtr:id><gtr:outcomeId>56d983d1c7f5d7.29822614</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2907115</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SynbiCITE - Innovation and Knowledge Centre in Synthetic Biology - Collaborative Programme - Tranche 1</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/M006700/1</gtr:fundingRef><gtr:id>E0E6E5A1-C198-4769-97F7-C2A846D2FDCD</gtr:id><gtr:outcomeId>56d9844ff0edd3.50459358</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Our DNA Assembly technology has been used by Industry</gtr:description><gtr:firstYearOfImpact>2014</gtr:firstYearOfImpact><gtr:id>E607ECB5-998A-4200-9106-6A17B64AE508</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56d99345c816a7.64955609</gtr:outcomeId><gtr:sector>Manufacturing, including Industrial Biotechology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have developed our DNA assembly technology, which was necessary for the design and build aspect of this proposal.
We have built and tested individual components of the design that we specified</gtr:description><gtr:exploitationPathways>The development of our DNA assembly methodology, although not a primary objective of this proposal has led to considerable other benefits, collaborations and further funding.</gtr:exploitationPathways><gtr:id>2E7F6989-DB86-4564-858E-A3EDD55F02D9</gtr:id><gtr:outcomeId>56d999b90b0dc4.19739389</gtr:outcomeId><gtr:sectors><gtr:sector>Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>This method provides for a highly scalable and efficient standardised method for assembling DNA parts to create new biological systems.</gtr:description><gtr:id>FD3CE1CE-91C6-46A7-998D-5F70FD7E531A</gtr:id><gtr:impact>High throughput DNA assembly is currently being implemented on an automated workflow for industrial collaboration.
We have collaborations with a number of academic and industrial partners to translate this technology.</gtr:impact><gtr:outcomeId>56d98a972bcfd4.66689156</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>BASIC DNA assembly</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>5A00C8B9-B5E2-41AE-AD6D-833BC496EEDD</gtr:id><gtr:title>R2oDNA designer: computational design of biologically neutral synthetic DNA sequences.</gtr:title><gtr:parentPublicationTitle>ACS synthetic biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/705485c811ca0a5575a71429e9edaefc"><gtr:id>705485c811ca0a5575a71429e9edaefc</gtr:id><gtr:otherNames>Casini A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2161-5063</gtr:issn><gtr:outcomeId>5460a4f289aba3.81932292</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C9DF0A3-9587-42C1-940B-D69094A078D7</gtr:id><gtr:title>Bricks and blueprints: methods and standards for DNA assembly.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Molecular cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/705485c811ca0a5575a71429e9edaefc"><gtr:id>705485c811ca0a5575a71429e9edaefc</gtr:id><gtr:otherNames>Casini A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-0072</gtr:issn><gtr:outcomeId>56d97a94a83164.81228588</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F1251C4-92CC-4252-8341-8A474FDABC34</gtr:id><gtr:title>BASIC: A New Biopart Assembly Standard for Idempotent Cloning Provides Accurate, Single-Tier DNA Assembly for Synthetic Biology.</gtr:title><gtr:parentPublicationTitle>ACS synthetic biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f41269b9d9aafd1998035813ce3ef2f"><gtr:id>7f41269b9d9aafd1998035813ce3ef2f</gtr:id><gtr:otherNames>Storch M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2161-5063</gtr:issn><gtr:outcomeId>5675e078c10e7</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/J020036/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>17F21DBC-4946-4262-AD07-9914F6EA12F7</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Bioengineering</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>FB535BD0-E265-4C0A-8532-32DCB83A3951</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Tools, technologies &amp; methods</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>18D298A9-FFE3-432F-B077-E3B703272E29</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biochemical engineering</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>F50F534E-2EE9-4970-AE8D-BAF7663379C5</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Development (Biosciences)</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>11093A5C-4232-4625-96BA-FC7E5BA96CE2</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Protein engineering</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>4A6E5CEB-ACA3-4301-98AD-C7EC310948FD</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Theoretical biology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>3493671D-A4CF-4197-90A7-3CCFBE1C0627</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Tools for the biosciences</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>